Abstract:Taxol (paclitaxel) response is profiled against a panel of clinical missence mutations in β‐tubulin at molecular and cellular levels, aiming to understanding of molecular mechanism and biological implication underlying drug resistance and sensitivity conferring from tubulin mutations. The Paclitaxel‐resistant mutations can be classified into three types, namely nonbonded interaction broken due to mutation, steric hindrance caused by mutation, and conformational change upon mutation. Taxol (paclitaxel) is the first approved microtubule‐stabilizing agent (MSA) by binding stoichiometrically to tubulin, which is considered to be one of the most significant advances in first‐line chemotherapy against diverse tumors. However, a large number of residue missence mutations harboring in the tubulin have been observed to cause acquired drug resistance, largely limiting the clinical application of Taxol and its analogs in chemotherapy. A systematic investigation of the intermolecular interactions between the Taxol and various tubulin mutants would help to establish a comprehensive picture of drug response to tubulin mutations in clinical treatment of cancer, and to design new MSA agents with high potency and selectivity to overcome drug resistance. In this study, we described an integration of in silico analysis and in vitro assay (iSiV) to profile Taxol against a panel of 149 clinically observed, cancer‐associated missence mutations in β‐tubulin at molecular and cellular levels, aiming to a systematic understanding of molecular mechanism and biological implication underlying drug resistance and sensitivity conferring from tubulin mutations. It is revealed that the Taxol‐resistant mutations can be classified into three types: (I) nonbonded interaction broken due to mutation, (II) steric hindrance caused by mutation, and (III) conformational change upon mutation. In addition, we identified three new Taxol‐resistant mutations (C239Y, T274I, and R320P) that can largely reduce the binding affinity of Taxol to tubulin at molecular level, in which the T274I and R320P were observed to considerably impair the antitumor activity of Taxol at cellular level. Moreover, a novel drug‐susceptible mutation (M363T) was also identified, which improves Taxol affinity by 2.6‐fold and decreases Taxol antitumor EC50 values from 29.4 to 18.7 μM.

Promotion of microtubule assembly in vitro by taxol

Study on Taxol in Inhibiting Human Leukemia Cell Proliferation and Inducing Apoptosis

Expression of recombinant alpha and beta tubulins from the yew Taxus cuspidata and analysis of the microtubule assembly in the presence of taxol

Taxol Biosynthesis and Molecular Genetics

Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels

Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents

Modulation of taxane binding to tubulin curved and straight conformations by systematic 3′N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency

Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments.

Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation

Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest

Strategies in Taxol development. A review.

Effect of Taxol on Adhesion, Invasion and Migration of MDA-MB-435 Highly Metastatic Human Breast Cancer Cells

A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel

Relationship between β-tubulin mRNA expression and sensitivity to docetaxel in malignant effusions from non small-cell lung cancer (NSCLC) and gastric cancer patients

The early stages of taxol biosynthesis: an interim report on the synthesis and identification of early pathway metabolites

Drugs That Changed Society: Microtubule-Targeting Agents Belonging to Taxanoids, Macrolides and Non-Ribosomal Peptides

Biosynthesis of the highly oxygenated tetracyclic core skeleton of Taxol

Discovery of novel microtubule stabilizers targeting taxane binding site by applying molecular docking, molecular dynamics simulation, and anticancer activity testing

Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis

Taxol produced from endophytic fungi induces apoptosis in human breast, cervical and ovarian cancer cells

Taxol: biosynthesis, molecular genetics, and biotechnological applications